Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with distant organ metastases is considered incurable with currently available therap
Correspondence12 Dec 2024British Journal of Cancer P: 1-2 Age-related changes in mammary gland increase tumorigenesis Anna Kriebs Research Highlights05 Dec 2024Nature Aging Volume: 4, P: 1667 Copy number alterations in normal breast tissues revealed by single-cell whole-genome sequencing ...
今天小编又挖到一本新晋SCI期刊——Npj Breast Cancer，2016年创刊，今年获得首个影响因子，首个影响因子高达6分，JCR分区为1区，是新期刊中的一匹黑马！期刊介绍 杂志主页：https://www.nature.com/npjbcancer/ 主编介绍 该期刊的主编是美国纽约斯隆·凯特琳癌症中心的拉里·诺顿（Larry Norton）教授。拉里·诺顿（...
近日,《Nature npj Breast Cancer》在线发表了标题为“The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer”的研究文章,为乳腺癌中非典型聚糖-...
nature sci rep Breast cancer 来自 ResearchGate 喜欢 0 阅读量: 37 作者:A Rai,AV Menon,S Jalan 摘要: CRISPR screen is a powerful technique to study gene essentiality at genome scale. Based on our analysis of public CRISPR screen data, the essential genes selected in CRISPR screens can be ...
npj Breast Cancer是英国Nature集团于2014年创办的npj系列新刊之一,npj是the Nature Partner Journals(Nature伙伴杂志)的简称。 了解更多npj,请点击链接: https://www.nature.com/nature-research/open-access/nature-partner-journals 期刊信息 npj Breast Cancer杂志仅支持在线发表,属于Open Access杂志,由Nature杂志社与...
Systemic therapy for early-stage breast cancer: learning from the past to build the future 2022, Nature Reviews Clinical Oncology Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients with Pathologic Complete Response (ypT0 and ypN0) after Neoadjuvant Systemic Treatment for Omission of ...
This review is intended to create a foundational tool that will aid investigators when choosing a breast cancer cell line to use in multiple expanding areas such as epigenetic discovery, xenograft experimentation, and cancer prevention, among other areas. Keywords: breast cancer; cell lines; ...
Targeting the PI3K/AKT/MTOR Pathway in Estrogen Receptor-Positive Breast Cancer. Cancer Treat. Rev. 2014, 40, 862–871. [Google Scholar] [CrossRef] Costa, R.L.B.; Han, H.S.; Gradishar, W.J. Targeting the PI3K/AKT/MTOR Pathway in Triple-Negative Breast Cancer: A Review. Breast ...
Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original ...